![Heart Attack Diagnostics Market to Be Worth More than $22B in a Decade](https://www.g2intelligence.com/wp-content/uploads/2022/10/Nov2022.LIR_.HeartAttackDiagnosticsMarket-iStock-1800x1250-1-1080x675.jpg)
Heart Attack Diagnostics Market to Be Worth More than $22B in a Decade
Increasing incidences of heart disease, as well as technological advances, will drive growth over the next eight to 10 years, reports say.
Increasing incidences of heart disease, as well as technological advances, will drive growth over the next eight to 10 years, reports say.
Video telehealth during the early period of the COVID-19 quarantine was actually highly effective in providing accurate diagnoses, research shows.
Research offers new evidence that a test targeting blood-based biomarkers can predict someone’s risk of developing long COVID.
The developer of NGS-based companion diagnostics targets the growing neurology biomarker market.
While new FDA clearances of blood-based early detection tests for Alzheimer’s represent significant progress, limitations remain.